Improvement of the Intestinal Absorption of a Peptidomimetic, Boronic Acid Thrombin Inhibitor Possibly Utilizing the Oligopeptide Transporter
Authors:
- 1 November 1999
- journal article
- research article
- Published by Springer Nature in Pharmaceutical Research
- Vol. 16 (11) , 1786-1789
Abstract
No abstract availableThis publication has 14 references indexed in Scilit:
- New Inhibitors of Thrombin and Other Trypsin-like Proteases: Hydrogen Bonding of an Aromatic Cyano Group with a Backbone Amide of the P1 Binding Site Replaces Binding of a Basic Side ChainBiochemistry, 1997
- Restricted Intestinal Absorption of Some β-Lactam Antibiotics by an Energy-Dependent Efflux System in Rat IntestinePharmaceutical Research, 1997
- Molecular modeling study of structural requirements for the oligopeptide transporterJournal of Drug Targeting, 1996
- Intestinal Absorption Barriers and Transport Mechanisms, Including Secretory Transport, for a Cyclic Peptide, Fibrinogen AntagonistPharmaceutical Research, 1996
- Challenges in the development of orally bioavailable thrombin active site inhibitorsBlood Coagulation & Fibrinolysis, 1995
- Synthetic low-molecular weight thrombin inhibitors: molecular design and pharmacological profileTrends in Pharmacological Sciences, 1993
- Anticoagulant activity of a peptide boronic acid thrombin inhibitor by various routes of administration in ratsPeptides, 1991
- Structural Requirements for the Intestinal Mucosal-Cell Peptide Transporter: The Need for N-Terminal α-Amino GroupPharmaceutical Research, 1991
- The selective inhibition of thrombin by peptides of boroarginine.Journal of Biological Chemistry, 1990
- H+ coupled transport of p.o. cephalosporins via dipeptide carriers in rabbit intestinal brush-border membranes: difference of transport characteristics between cefixime and cephradine.The Journal of Pharmacology and Experimental Therapeutics, 1988